Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001737396-18-000001
Filing Date
2018-04-16
Accepted
2018-04-16 11:53:19
Documents
1
Effectiveness Date
2018-04-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7282
  Complete submission text file 0001737396-18-000001.txt   8368
Mailing Address 200 CLARENDON STREET FLOOR 45, MAILBOX 30 BOSTON MA 02215
Business Address 200 CLARENDON STREET FLOOR 45, MAILBOX 30 BOSTON MA 02215 5109138357
Stargazer Pharmaceuticals, Inc. (Filer) CIK: 0001737396 (see all company filings)

EIN.: 824973549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-310231 | Film No.: 18755956